Clinical Trials Sponsored by Ono Pharmaceutical Co. Ltd

Total 3754 results

Ono Pharmaceutical Co. Ltd

Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Gastric Cancer

Japan
Ono Pharmaceutical Co. Ltd

Recruiting

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Primary CNS Lymphoma | Refractory Primary Central Nervous System Lymphoma

United States
Ono Pharmaceutical Co. Ltd

Completed

ONO-7913 Phase I Study (ONO-7913)

Solid Tumor

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer

Gastric Cancer

Japan, Korea, Republic of, Taiwan
Ono Pharmaceutical Co. Ltd

Completed

Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects

Healthy Volunteers

Japan
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Phase I Study in Patients With Solid Tumor

Advanced Solid Tumors | Recurrent Solid Tumors

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-8577 in Patients With Overactive Bladder

Overactive Bladder

Japan
Ono Pharmaceutical Co. Ltd

Completed

A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women

Healthy Post Menopausal Women

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Overactive Bladder
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-8539 in Patients With Overactive Bladder

Overactive Bladder

Poland, Ukraine, Romania, Russian Federation, Czech Republic, Hungary, Netherlands, Sweden, Germany
Ono Pharmaceutical Co. Ltd

Completed

ONO-7436 Phase II Study in Japan

Malignant Tumor

Japan
Ono Pharmaceutical Co. Ltd

Completed

ONO-7746 Study in Healthy Adult Subject

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Coronary Artery Disease

Japan
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

Community-acquired Pneumonia

Japan
Ono Pharmaceutical Co. Ltd

Completed

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Belgium, France, Austria, Germany, Italy, Netherlands, Switzerland, United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-1078 in Patients With Chronic Sinusitis

Chronic Sinusitis

Japan
Ono Pharmaceutical Co. Ltd
Kyorin Pharmaceutical Co.,Ltd

Completed

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

Overactive Bladder

Japan
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)

Alzheimer's Disease

Japan
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Ono Pharmaceutical Co. Ltd

Recruiting

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Multiple System Atrophy (MSA)

United States
Ono Pharmaceutical Co. Ltd

Recruiting

A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Lymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-Cell

United States
Ono Pharmaceutical Co. Ltd

Recruiting

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

Plaque Psoriasis

United Kingdom, Moldova, Republic of, Romania
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Phase I Study in Patients With Solid Tumor

Advanced Solid Tumors | Recurrent Solid Tumors

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Completed

A Phase 1 Study of ONO-2020 in Healthy Participants

Healthy Volunteers

United States
Ono Pharmaceutical Co. Ltd

Completed

Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

Healthy Volunteers

Japan
Ono Pharmaceutical Co. Ltd

Completed

A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

SARS-CoV-2 Infection (COVID-19)

Japan
Ono Pharmaceutical Co. Ltd

Active, not recruiting

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Japan
Ono Pharmaceutical Co. Ltd

Completed

Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Japan
Ono Pharmaceutical Co. Ltd

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects

Healthy Volunteers

Japan
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers

Osteoarthritis

Denmark, United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)

Ocular Hypertension | Open Angle-glaucoma

United States
Ono Pharmaceutical Co. Ltd

Completed

A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers

Acid Reflux

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

Postoperative Supraventricular Tachyarrythmia
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Involutional Osteoporosis
Ono Pharmaceutical Co. Ltd

Completed

ONO-7746 Study in Healthy Adult Subjects

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Ono Pharmaceutical Co. Ltd

Completed

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Belgium, France, Germany, Italy, Netherlands, Switzerland, United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-2506 in Patients With Acute Ischemic Stroke

Stroke

Japan
Ono Pharmaceutical Co. Ltd

Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Relapsed or Refractory T Cell Lymphoma

United States
Ono Pharmaceutical Co. Ltd

Recruiting

ONO-4538 Phase II Rollover Study (ONO-4538-98)

Pan-tumor

Japan, Korea, Republic of, Taiwan
Ono Pharmaceutical Co. Ltd

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Gastric Cancer

Korea, Republic of, Taiwan, Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-4538 in Gastric Cancer

Gastric Cancer

Japan, Korea, Republic of, Taiwan
Ono Pharmaceutical Co. Ltd

Terminated

A Study of ONO-7475 in Patients With Acute Leukemias

Myelodysplastic Syndromes | Acute Leukemia

United States
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

Taiwan
Ono Pharmaceutical Co. Ltd

Completed

ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

Malignant Solid Tumor

Japan
Ono Pharmaceutical Co. Ltd

Completed

A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers

Venous Thromboembolism

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788 (ONO-5788-02)

Acromegaly

Netherlands

3

Subscribe